Association between severe treatment‐related lymphopenia and progression‐free survival in patients with newly diagnosed squamous cell head and neck cancer
Head & Neck2013Vol. 36(12), pp. 1747–1753
Citations Over TimeTop 10% of 2013 papers
Abstract
Baseline total lymphocyte counts were normal, but at 2 months approximately 60% of patients had severe treatment-related lymphopenia regardless of HPV status. Severe treatment-related lymphopenia in HPV- patients is independently associated with earlier disease progression. Prospective studies are needed to confirm these findings, which suggest that immune preservation is important in this cancer.
Related Papers
- → Risks of Subsequent Hospitalization and Death in Patients with Kidney Disease(2012)106 cited
- → Impact of Frailty on Clinical Outcomes in Patients With Critical Limb Ischemia(2018)103 cited
- → Prognostic Significance of Young Age (<35 Years) by Subtype Based on ER, PR, and HER2 Status in Breast Cancer: A Nationwide Registry‐Based Study(2011)80 cited
- → Mortality following durable left ventricular assist device implantation by timing and type of first infection(2021)18 cited
- → A Study on Chocolate Consumption in Prospective Teachers(2016)1 cited